coVita™ LLC, a frontrunner in superior breath evaluation and diagnostic options, serves because the U.S. distributor for the revolutionary NObreath® Fractional Exhaled Nitric Oxide (FeNO) gadget from UK-based Bedfont® Scientific Ltd. The brand new settlement with Allergy Companions marks the end result of a strategic partnership developed over the previous two years.
“The partnership established between coVita™ and Allergy Companions marks necessary progress in broadening entry to FeNO know-how on a world scale.” Stated Jason Smith, CEO at Bedfont®. “We’re happy to assist this collaboration and happy with the position coVita™ is enjoying in advancing high-quality bronchial asthma care.”
Because the nation’s largest and most trusted built-in community of allergy and bronchial asthma specialists, Allergy Companions serves sufferers by way of greater than 125 areas in over 20 states. Below the brand new settlement, all Allergy Companions clinics will present FeNO testing with the NObreath® gadget, enhancing affected person entry to superior, non-invasive instruments that support in bronchial asthma prognosis and administration. The NObreath® is the allergist’s gadget of selection within the USA, additional underscoring its worth in supporting correct evaluation and customized remedy. With 26.8 million People, 8.2 % of the U.S. inhabitants, affected by bronchial asthma in 2022, the necessity for revolutionary instruments to assist higher care and illness administration has by no means been larger.
We’re extremely happy with our collaboration with Allergy Companions and thrilled to assist them implement the NObreath® FeNO know-how. Their willpower to combine FeNO testing throughout their whole community of suppliers is illustrative of their understanding of the important position goal FeNO monitoring performs within the trendy medical setting.”
Jason Aversano, CEO, coVita™
Bedfont® Scientific, producer of the NObreath®, and coVita™, share a long-standing partnership grounded in mutual respect, belief, and a shared imaginative and prescient to enhance respiratory well being by way of innovation. Over time, the 2 firms have labored hand in hand to make superior breath evaluation extra accessible to clinicians and sufferers all through the USA. Their collaboration continues to exemplify how aligned values and world cooperation can drive significant change in healthcare.
